Number of the records: 1
The Neuroactive Steroid Pregnanolone Glutamate: Anticonvulsant Effect, Metabolites and Its Effect on Neurosteroid Levels in Developing Rat Brains
- 1.
SYSNO ASEP 0551648 Document Type J - Journal Article R&D Document Type Journal Article Subsidiary J Článek ve WOS Title The Neuroactive Steroid Pregnanolone Glutamate: Anticonvulsant Effect, Metabolites and Its Effect on Neurosteroid Levels in Developing Rat Brains Author(s) Kudová, Eva (UOCHB-X) RID, ORCID
Mareš, Pavel (FGU-C) RID, ORCID
Hill, M. (CZ)
Vondráková, Kateřina (FGU-C) RID, ORCID, SAI
Tsenov, Grygoriy (FGU-C) RID, ORCID
Chodounská, Hana (UOCHB-X) RID, ORCID
Kubová, Hana (FGU-C) RID, ORCID
Valeš, Karel (FGU-C) RID, ORCID, SAIArticle number 49 Source Title Pharmaceuticals. - : MDPI
Roč. 15, č. 1 (2022)Number of pages 19 s. Language eng - English Country CH - Switzerland Keywords neurosteroids ; anticonvulsant ; zuranolone ; NMDA ; GABA ; metabolomics OECD category Organic chemistry R&D Projects EF16_025/0007444 GA MZd - Ministry of Health (MZ) NU20-04-00389 GA MZd - Ministry of Health (MZ) Method of publishing Open access Institutional support UOCHB-X - RVO:61388963 ; FGU-C - RVO:67985823 UT WOS 000757087600001 EID SCOPUS 85122128797 DOI 10.3390/ph15010049 Annotation Pregnanolone glutamate (PA-G) is a neuroactive steroid that has been previously demonstrated to be a potent neuroprotective compound in several biological models in vivo. Our in vitro experiments identified PA-G as an inhibitor of N-methyl-D-aspartate receptors and a potentiator of γ-aminobutyric acid receptors (GABAARs). In this study, we addressed the hypothesis that combined GABAAR potentiation and NMDAR antagonism could afford a potent anticonvulsant effect. Our results demonstrated the strong age-related anticonvulsive effect of PA-G in a model of pentylenetetrazol-induced seizures. PA-G significantly decreased seizure severity in 12-day-old animals, but only after the highest dose in 25-day-old animals. Interestingly, the anticonvulsant effect of PA-G differed both qualitatively and quantitatively from that of zuranolone, an investigational neurosteroid acting as a potent positive allosteric modulator of GABAARs. Next, we identified 17-hydroxy-pregnanolone (17-OH-PA) as a major metabolite of PA-G in 12-day-old animals. Finally, the administration of PA-G demonstrated direct modulation of unexpected neurosteroid levels, namely pregnenolone and dehydroepiandrosterone sulfate. These results suggest that compound PA-G might be a pro-drug of 17-OH-PA, a neurosteroid with a promising neuroprotective effect with an unknown mechanism of action that may represent an attractive target for studying perinatal neural diseases. Workplace Institute of Organic Chemistry and Biochemistry Contact asep@uochb.cas.cz ; Kateřina Šperková, Tel.: 232 002 584 ; Viktorie Chládková, Tel.: 232 002 434 Year of Publishing 2023 Electronic address https://www.mdpi.com/1424-8247/15/1/49
Number of the records: 1